Post-transcriptional regulation controlled by E-cadherin is important for c-Jun activity in melanoma

Pigment Cell and Melanoma Research

Volumn 24, Issue 1, 2011, Pages 148-164

  Spangler, B ^a   Vardimon, L ^b   Bosserhoff, A K ^a   Kuphal, S ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

C Jun; Cytoskeleton; E cadherin; Malignant melanoma; Post transcriptional regulation

Indexed keywords

PROTEIN C JUN; UVOMORULIN;

ARTICLE; CARCINOGENESIS; CELL ADHESION; CYTOSKELETON; HUMAN; HUMAN CELL; MELANOCYTE; MELANOMA; MELANOMA CELL; ONCOGENE C JUN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; TRANSCRIPTION REGULATION;

CADHERINS; CELL ADHESION; CELL LINE, TUMOR; CYTOSKELETON; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELANOMA; MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-JUN; TRANSCRIPTION, GENETIC;

EID: 78651458117     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/j.1755-148X.2010.00787.x     Document Type: Article

References (64)

1. Andersen, H., Mejlvang, J., Mahmood, S., Gromova, I., Gromov, P., Lukanidin, E., Kriajevska, M., Mellon, J.K., and Tulchinsky, E. (2005). Immediate and delayed effects of E-cadherin inhibition on gene regulation and cell motility in human epidermoid carcinoma cells. Mol. Cell. Biol. 25, 9138-9150.
2. Bernstein, L.R., and Colburn, N.H. (1989). AP1/jun function is differentially induced in promotion-sensitive and resistant JB6 cells. Science 244, 566-569.
3. Berx, G., Cleton-Jansen, A.M., Nollet, F., de Leeuw, W.J., van de Vijver, M., Cornelisse, C., and van Roy, F. (1995). E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J. 14, 6107-6115.
4. Blattner, C., Kannouche, P., Litfin, M., Bender, K., Rahmsdorf, H.J., Angulo, J.F., and Herrlich, P. (2000). UV-Induced stabilization of c-fos and other short-lived mRNAs. Mol. Cell. Biol. 20, 3616-3625.
5. Boukamp, P., Dzarlieva-Petrusevska, R.T., Breitkreuz, D., Hornung, J., Markham, A., and Fusenig, N.E. (1988). Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106, 761-771.
6. Bowden, G.T., Schneider, B., Domann, R., and Kulesz-Martin, M. (1994). Oncogene activation and tumor suppressor gene inactivation during multistage mouse skin carcinogenesis. Cancer Res. 54, 1882s-1885s.
7. Brenner, D.A., O'Hara, M., Angel, P., Chojkier, M., and Karin, M. (1989). Prolonged activation of jun and collagenase genes by tumour necrosis factor-alpha. Nature 337, 661-663.
8. Cruz-Munoz, W., Man, S., Xu, P., and Kerbel, R.S. (2008). Development of a preclinical model of spontaneous human melanoma central nervous system metastasis. Cancer Res. 68, 4500-4505.
9. Deng, T., and Karin, M. (1994). c-Fos transcriptional activity stimulated by H-Ras-activated protein kinase distinct from JNK and ERK. Nature 371, 171-175.
10. Devary, Y., Gottlieb, R.A., Lau, L.F., and Karin, M. (1991). Rapid and preferential activation of the c-jun gene during the mammalian UV response. Mol. Cell. Biol. 11, 2804-2811.
11. Devary, Y., Gottlieb, R.A., Smeal, T., and Karin, M. (1992). The mammalian ultraviolet response is triggered by activation of Src tyrosine kinases. Cell 71, 1081-1091.
12. Dhar, A., Young, M.R., and Colburn, N.H. (2002). The role of AP-1, NF-kappaB and ROS/NOS in skin carcinogenesis: the JB6 model is predictive. Mol. Cell. Biochem. 234-235, 185-193.
13. Dong, Z., Birrer, M.J., Watts, R.G., Matrisian, L.M., and Colburn, N.H. (1994). Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. Proc. Natl. Acad. Sci. USA 91, 609-613.
14. Eferl, R., and Wagner, E.F. (2003). AP-1: a double-edged sword in tumorigenesis. Nat. Rev. Cancer 3, 859-868.
15. Furukawa, F., Fujii, K., Horiguchi, Y., Matsuyoshi, N., Fujita, M., Toda, K., Imamura, S., Wakita, H., Shirahama, S., and Takigawa, M. (1997). Roles of E- and P-cadherin in the human skin. Microsc. Res. Tech. 38, 343-352.
16. Grady, W.M., Willis, J., Guilford, P.J. et al. (2000). Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat. Genet. 26, 16-17.
17. Guilford, P., Hopkins, J., Harraway, J., McLeod, M., McLeod, N., Harawira, P., Taite, H., Scoular, R., Miller, A., and Reeve, A.E. (1998). E-cadherin germline mutations in familial gastric cancer. Nature 392, 402-405.
18. Gupta, S., Campbell, D., Derijard, B., and Davis, R.J. (1995). Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 267, 389-393.
19. Halaban, R., Kwon, B.S., Ghosh, S., Delli, B.P., and Baird, A. (1988). bFGF as an autocrine growth factor for human melanomas. Oncogene Res. 3, 177-186.
20. Hendrix, M.J., Seftor, E.A., Chu, Y.W., Trevor, K.T., and Seftor, R.E. (1996). Role of intermediate filaments in migration, invasion and metastasis. Cancer Metastasis Rev. 15, 507-525.
21. Hsu, M.Y., Wheelock, M.J., Johnson, K.R., and Herlyn, M. (1996). Shifts in cadherin profiles between human normal melanocytes and melanomas. J. Investig. Dermatol. Symp. Proc. 1, 188-194.
22. Hsu, M.Y., Meier, F.E., Nesbit, M., Hsu, J.Y., Van Belle, P., Elder, D.E., and Herlyn, M. (2000). E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. Am. J. Pathol. 156, 1515-1525.
23. Jacob, K., Wach, F., Holzapfel, U., Hein, R., Lengyel, E., Buettner, R., and Bosserhoff, A.K. (1998). In vitro modulation of human melanoma cell invasion and proliferation by all-trans-retinoic acid. Melanoma Res. 8, 211-219.
24. Jankowski, J.A., Bruton, R., Shepherd, N., and Sanders, D.S. (1997). Cadherin and catenin biology represent a global mechanism for epithelial cancer progression. Mol. Pathol. 50, 289-290.
25. Jochum, W., Passegue, E., and Wagner, E.F. (2001). AP-1 in mouse development and tumorigenesis. Oncogene 20, 2401-2412.
26. Karin, M. (1995). The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270, 16483-16486.
27. Kennedy, N.J., and Davis, R.J. (2003). Role of JNK in tumor development. Cell Cycle 2, 199-201.
28. Knirsh, R., Ben Dror, I., Spangler, B., Matthews, G.D., Kuphal, S., Bosserhoff, A.K., and Vardimon, L. (2009). Loss of E-cadherin mediated cell-cell contacts activates a novel mechanism for upregulation of the proto-oncogene c-Jun. Mol. Biol. Cell. 20, 2121-9.
29. Knudsen, K.A., Soler, A.P., Johnson, K.R., and Wheelock, M.J. (1995). Interaction of alpha-actinin with the cadherin/catenin cell-cell adhesion complex via alpha-catenin. J. Cell Biol. 130, 67-77.
30. Kolbus, A., Herr, I., Schreiber, M., Debatin, K.M., Wagner, E.F., and Angel, P. (2000). c-Jun-dependent CD95-L expression is a rate-limiting step in the induction of apoptosis by alkylating agents. Mol. Cell. Biol. 20, 575-582.
31. Kolomeichuk, S.N., Terrano, D.T., Lyle, C.S., Sabapathy, K., and Chambers, T.C. (2008). Distinct signaling pathways of microtubule inhibitors - vinblastine and Taxol induce JNK-dependent cell death but through AP-1-dependent and AP-1-independent mechanisms, respectively. FEBS J. 275, 1889-1899.
32. Kovary, K., and Bravo, R. (1991). The jun and fos protein families are both required for cell cycle progression in fibroblasts. Mol. Cell. Biol. 11, 4466-4472.
33. Kuphal, S., and Bosserhoff, A.K. (2006). Influence of the cytoplasmic domain of E-cadherin on endogenous N-cadherin expression in malignant melanoma. Oncogene 25, 248-259.
34. Kuphal, S., Poser, I., Jobin, C., Hellerbrand, C., and Bosserhoff, A.K. (2004). Loss of E-cadherin leads to upregulation of NFkappaB activity in malignant melanoma. Oncogene 23, 8509-8519.
35. Lopez-Bergami, P., Habelhah, H., Bhoumik, A., Zhang, W., Wang, L.H., and Ronai, Z. (2005). RACK1 mediates activation of JNK by protein kinase C. Mol. Cell 19, 309-320.
36. Lopez-Bergami, P., Huang, C., Goydos, J.S. et al. (2007). Rewired ERK-JNK signaling pathways in melanoma. Cancer Cell 11, 447-460.
37. Marinissen, M.J., Chiariello, M., Tanos, T., Bernard, O., Narumiya, S., and Gutkind, J.S. (2004). The small GTP-binding protein RhoA regulates c-jun by a ROCK-JNK signaling axis. Mol. Cell 14, 29-41.
38. Massoumi, R., Kuphal, S., Hellerbrand, C., Haas, B., Wild, P., Spruss, T., Pfeifer, A., Fassler, R., and Bosserhoff, A.K. (2009). Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma. J. Exp. Med. 206, 221-232.
39. Meier, F., Caroli, U., Satyamoorthy, K. et al. (2003). Fibroblast growth factor-2 but not Mel-CAM and/or beta3 integrin promotes progression of melanocytes to melanoma. Exp. Dermatol. 12, 296-306.
40. Mils, V., Piette, J., Barette, C., Veyrune, J., Tesniere, A., Escot, C., Guilhou, J.J., and Basset-Seguin, N. (1997). The proto-oncogene c-fos increases the sensitivity of keratinocytes to apoptosis. Oncogene 14, 1555-1561.
41. Nobes, C.D., and Hall, A. (1995). Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 81, 53-62.
42. Onder, T.T., Gupta, P.B., Mani, S.A., Yang, J., Lander, E.S., and Weinberg, R.A. (2008). Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res. 68, 3645-3654.
43. Ozawa, M., and Kemler, R. (1992). Molecular organization of the uvomorulin-catenin complex. J. Cell Biol. 116, 989-996.
44. Ozawa, M., Ringwald, M., and Kemler, R. (1990). Uvomorulin-catenin complex formation is regulated by a specific domain in the cytoplasmic region of the cell adhesion molecule. Proc. Natl. Acad. Sci. USA 87, 4246-4250.
45. Pla, P., Moore, R., Morali, O.G., Grille, S., Martinozzi, S., Delmas, V., and Larue, L. (2001). Cadherins in neural crest cell development and transformation. J. Cell. Physiol. 189, 121-132.
46. Polak, P., Oren, A., Ben Dror, I., Steinberg, D., Sapoznik, S., Arditi-Duvdevany, A., and Vardimon, L. (2006). The cytoskeletal network controls c-Jun translation in a UTR-dependent manner. Oncogene 25, 665-676.
47. Poser, I., and Bosserhoff, A.K. (2004). Transcription factors involved in development and progression of malignant melanoma. Histol. Histopathol. 19, 173-188.
48. Poser, I., Dominguez, D., de Herreros, A.G., Varnai, A., Buettner, R., and Bosserhoff, A.K. (2001). Loss of E-cadherin expression in melanoma cells involves up-regulation of the transcriptional repressor Snail. J. Biol. Chem. 276, 24661-24666.
49. Poser, I., Tatzel, J., Kuphal, S., and Bosserhoff, A.K. (2004). Functional role of MIA in melanocytes and early development of melanoma. Oncogene 23, 6115-6124.
50. Pulverer, B.J., Kyriakis, J.M., Avruch, J., Nikolakaki, E., and Woodgett, J.R. (1991). Phosphorylation of c-jun mediated by MAP kinases. Nature 353, 670-674.
51. Rimm, D.L., Sinard, J.H., and Morrow, J.S. (1995). Reduced alpha-catenin and E-cadherin expression in breast cancer. Lab. Invest. 72, 506-512.
52. Rutberg, S.E., Goldstein, I.M., Yang, Y.M., Stackpole, C.W., and Ronai, Z. (1994). Expression and transcriptional activity of AP-1, CRE, and URE binding proteins in B16 mouse melanoma subclones. Mol. Carcinog. 10, 82-87.
53. Ryder, K., and Nathans, D. (1988). Induction of protooncogene c-jun by serum growth factors. Proc. Natl. Acad. Sci. USA 85, 8464-8467.
54. Sanders, D.S., Blessing, K., Hassan, G.A., Bruton, R., Marsden, J.R., and Jankowski, J. (1999). Alterations in cadherin and catenin expression during the biological progression of melanocytic tumours. Mol. Pathol. 52, 151-157.
55. Shaulian, E., and Karin, M. (2001). AP-1 in cell proliferation and survival. Oncogene 20, 2390-2400.
56. Shaulian, E., Schreiber, M., Piu, F., Beeche, M., Wagner, E.F., and Karin, M. (2000). The mammalian UV response: c-Jun induction is required for exit from p53-imposed growth arrest. Cell 103, 897-907.
57. Silye, R., Karayiannakis, A.J., Syrigos, K.N. et al. (1998). E-cadherin/catenin complex in benign and malignant melanocytic lesions. J. Pathol. 186, 350-355.
58. Smeal, T., Binetruy, B., Mercola, D.A., Birrer, M., and Karin, M. (1991). Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73. Nature 354, 494-496.
59. Sommers, C.L., Gelmann, E.P., Kemler, R., Cowin, P., and Byers, S.W. (1994). Alterations in beta-catenin phosphorylation and plakoglobin expression in human breast cancer cells. Cancer Res. 54, 3544-3552.
60. Stappert, J., and Kemler, R. (1994). A short core region of E-cadherin is essential for catenin binding and is highly phosphorylated. Cell Adhes. Commun. 2, 319-327.
61. Weiss, C., and Bohmann, D. (2004). Deregulated repression of c-Jun provides a potential link to its role in tumorigenesis. Cell Cycle 3, 111-113.
62. Wenke, A.K., Kjellman, C., Lundgren-Akerlund, E., Uhlmann, C., Haass, N.K., Herlyn, M., and Bosserhoff, A.K. (2007). Expression of integrin alpha10 is induced in malignant melanoma. Cell. Oncol. 29, 373-386.
63. Xiao, L., and Lang, W. (2000). A dominant role for the c-Jun NH2-terminal kinase in oncogenic ras-induced morphologic transformation of human lung carcinoma cells. Cancer Res. 60, 400-408.
64. Zenz, R., Scheuch, H., Martin, P., Frank, C., Eferl, R., Kenner, L., Sibilia, M., and Wagner, E.F. (2003). c-Jun regulates eyelid closure and skin tumor development through EGFR signaling. Dev. Cell 4, 879-889.